Skip to Main Content

Paper Details

Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
Nat Genet
148
2018
BRCA2, CHD1, ETS, ETS fusion, ETS fusion-negative cancers, FOXA1, NEAT1, Prostate cancer, cancer, cancer genes, cancers, prostate cancer, prostate cancers, putative driver genes, whole genomes
Adult, Aged, Aged, 80 and over, BRCA2 Protein, Disease Progression, Hepatocyte Nuclear Factor 3-alpha, High-Throughput Nucleotide Sequencing, Humans, Male, Middle Aged, Mutation, Oncogenes, Prostatic Neoplasms
Author NameAffiliation
David C WedgeOxford Big Data Institute, University of Oxford
David C WedgeWellcome Trust Sanger Institute
David C WedgeOxford NIHR Biomedical Research Centre
Gunes GundemWellcome Trust Sanger Institute
Gunes GundemMemorial Sloan-Kettering Cancer Center
Thomas J MitchellWellcome Trust Sanger Institute
Thomas J MitchellAddenbrooke's Hospital
Thomas J MitchellCambridge Institute
Dan J WoodcockOxford Big Data Institute, University of Oxford
Inigo MartincorenaWellcome Trust Sanger Institute
Mohammed J R GhoriWellcome Trust Sanger Institute
Jorge ZamoraWellcome Trust Sanger Institute
Adam ButlerWellcome Trust Sanger Institute
Hayley C WhitakerUniversity College London
Zsofia Kote-JaraiThe Institute of Cancer Research
Ludmil B AlexandrovWellcome Trust Sanger Institute
Ludmil B AlexandrovWellcome Trust Sanger Institute
Peter Van LooWellcome Trust Sanger Institute
Peter Van LooThe Francis Crick Institute
Charlie E MassieCambridge Institute
Charlie E MassieUniversity of Cambridge
Stefan C DentroOxford Big Data Institute, University of Oxford
Stefan C DentroWellcome Trust Sanger Institute
Stefan C DentroThe Francis Crick Institute
Anne Y WarrenCambridge University Hospitals NHS Foundation Trust
Clare VerrillOxford NIHR Biomedical Research Centre
Clare VerrillUniversity of Oxford
Daniel M BerneyBarts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London
Nening DennisRoyal Marsden NHS Foundation Trust
Sue MersonThe Institute of Cancer Research
Steve HawkinsCambridge Institute
William J HowatCambridge University Hospitals NHS Foundation Trust
William J HowatCambridge University Hospitals NHS Foundation Trust
Yong-Jie LuBarts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London
Adam LambertUniversity of Oxford
Jonathan KayUniversity College London
Barbara KremeyerWellcome Trust Sanger Institute
Katalin Kar??sziUniversity of Oxford
Hayley J LuxtonUniversity College London
Niedzica CamachoMemorial Sloan-Kettering Cancer Center
Niedzica CamachoThe Institute of Cancer Research
Luke MarsdenUniversity of Oxford
Sandra EdwardsThe Institute of Cancer Research
Lucy MatthewsUniversity of Oxford
Valeria BoCancer Research UK Cambridge Institute
Daniel LeongamornlertWellcome Trust Sanger Institute
Daniel LeongamornlertThe Institute of Cancer Research
Stuart McLarenWellcome Trust Sanger Institute
Anthony NgThe Chinese University of Hong Kong
Yongwei YuSecond Military Medical University
  • 1 - 50

Datasets

Dataset
Description
Source Link
CanSARIntegrated cancer research and drug discovery resourceLink
CanSARIntegrated cancer research and drug discovery resourceLink
CanSARIntegrated cancer research and drug discovery resourceLink
CanSARIntegrated cancer research and drug discovery resourceLink
Release 1.2